We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Detection Of Low-Abundance Serum Proteins Associated With Prediabetes For Predictive And Prognostic Purposes
Whitepaper

Detection Of Low-Abundance Serum Proteins Associated With Prediabetes For Predictive And Prognostic Purposes

Detection Of Low-Abundance Serum Proteins Associated With Prediabetes For Predictive And Prognostic Purposes
Whitepaper

Detection Of Low-Abundance Serum Proteins Associated With Prediabetes For Predictive And Prognostic Purposes

Diabetes mellitus refers to a family of metabolic disorders that are characterized by elevated blood glucose concentrations, or hyperglycemia. The International Diabetes Federation estimated that in 2015 there were 415 million diabetes cases worldwide in the 20-79 year old age group and predicted that number to increase to 640 million by 2040.

Download this whitepaper to uncover:

  • Predicting disease onset via clinical biomarkers
  • Applying the SomaScan® Assay to accurately identify serum proteins associated with diabetic risk and outcome
  • Other potential applications for the SomaScan® Assay in diabetes research
Advertisement